ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Tolnaftate: Drug information

Tolnaftate: Drug information
(For additional information see "Tolnaftate: Patient drug information" and see "Tolnaftate: Pediatric drug information")

For abbreviations, symbols, and age group definitions used in Lexicomp (show table)
Brand Names: US
  • Anti-Fungal [OTC] [DSC];
  • Antifungal (Tolnaftate) [OTC];
  • Dr Gs Clear Nail [OTC];
  • Formula 3 The Treatment [OTC];
  • Formula 7 The Solution [OTC];
  • FT Antifungal [OTC];
  • Fungi-Guard [OTC];
  • Fungoid-D [OTC] [DSC];
  • LamISIL AF Defense [OTC] [DSC];
  • Micomitin [OTC];
  • Micotrin AL [OTC];
  • Mycocide Clinical NS [OTC];
  • Mycozyl AL;
  • Mycozyl AL [OTC];
  • Tinactin Deodorant [OTC];
  • Tinactin [OTC];
  • Tinaspore [OTC];
  • TM-Tolnaftate LR [OTC];
  • TM-Tolnaftate [OTC];
  • Tolnafi-AL [OTC]
Pharmacologic Category
  • Antifungal Agent, Topical
Dosing: Adult
Tinea infections

Tinea infections:

Tinea corporis/tinea cruris: Topical: Apply to affected and surrounding area(s) twice daily until clinical resolution, typically 1 to 4 weeks (Ref).

Tinea pedis (labeled use)/tinea manuum (off-label use):

Treatment: Topical: Apply to affected and surrounding area(s) twice daily until 1 week after clinical resolution, typically for 4 weeks total (Ref).

Prevention (tinea pedis only): Topical: Apply once or twice daily.

Dosing: Kidney Impairment: Adult

There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.

Dosing: Hepatic Impairment: Adult

There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.

Dosing: Older Adult

Refer to adult dosing.

Dosing: Pediatric

(For additional information see "Tolnaftate: Pediatric drug information")

Tinea pedis

Tinea pedis:

Treatment: Children ≥2 years and Adolescents: Topical: Apply twice daily for 4 weeks

Prevention: Children ≥2 years and Adolescents: Topical: Apply once or twice daily.

Tinea corporis, treatment

Tinea corporis, treatment: Children ≥2 years and Adolescents: Topical: Apply twice daily for 4 weeks.

Tinea cruris, treatment

Tinea cruris, treatment: Children ≥2 years and Adolescents: Topical: Apply twice daily for 2 weeks.

Dosing: Kidney Impairment: Pediatric

There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.

Dosing: Hepatic Impairment: Pediatric

There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption.

Adverse Reactions

The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Frequency not defined.

Dermatologic: Contact dermatitis, pruritus, stinging of the skin

Local: Irritation

Contraindications

OTC labeling: When used for self-medication, do not use on children <2 years of age.

Warnings/Precautions

Concerns related to adverse effects:

• Irritation: Discontinue if sensitivity or irritation occurs.

Other warnings/precautions:

• Self-medication (OTC use): When used for self-medication (OTC use), contact health care provider if condition does not improve within 4 weeks. Avoid contact with eyes. Not effective on the scalp.

Warnings: Additional Pediatric Considerations

Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, >3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures and respiratory depression; use caution (AAP 1997; Shehab 2009).

Dosage Forms: US

Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product

Aerosol, External:

Tinactin: 1% (150 g [DSC])

Aerosol Powder, External:

LamISIL AF Defense: 1% (133 g [DSC])

Tinactin: 1% (133 g)

Tinactin Deodorant: 1% (133 g)

Cream, External:

Antifungal (Tolnaftate): 1% (14.18 g) [odorless]

FT Antifungal: 1% (15 g)

Fungi-Guard: 1% (15 g)

Fungoid-D: 1% (113 g [DSC]) [contains cetyl alcohol, methylparaben, propylene glycol, propylparaben, trolamine (triethanolamine)]

Tinactin: 1% (15 g, 30 g [DSC])

Generic: 1% (14 g, 14.18 g, 15 g, 20 g, 28 g, 28.3 g, 30 g)

Powder, External:

Anti-Fungal: 1% (45 g [DSC])

Generic: 1% (45 g)

Solution, External:

Dr Gs Clear Nail: 1% (18 mL) [contains propylene glycol]

Formula 3 The Treatment: 1% (15 mL) [contains butylparaben, methylparaben, propylparaben, sesame oil]

Formula 7 The Solution: 1% (15 g) [contains disodium edta]

Micomitin: 1% (30 mL) [contains benzyl alcohol]

Micotrin AL: 1% (30 mL) [contains benzyl alcohol]

Mycocide Clinical NS: 1% (30 mL) [contains propylene glycol]

Mycozyl AL: 1% (10 mL, 30 mL) [contains benzyl alcohol]

Tinaspore: 1% (10 mL)

TM-Tolnaftate: 1% (30 mL, 45 mL)

TM-Tolnaftate LR: 1% (45 mL) [contains cetearyl alcohol, isopropyl alcohol]

Tolnafi-AL: 1% (30 mL)

Generic Equivalent Available: US

May be product dependent

Pricing: US

Cream (Tinactin External)

1% (per gram): $0.42

Cream (Tolnaftate External)

1% (per gram): $0.15 - $0.29

Powder (Tolnaftate External)

1% (per gram): $0.06 - $0.07

Solution (Formula 3 The Treatment External)

1% (per mL): $1.08

Solution (Formula 7 The Solution External)

1% (per gram): $1.36

Solution (Micomitin External)

1% (per mL): $56.50

Solution (Micotrin AL External)

1% (per mL): $75.00

Solution (Mycozyl AL External)

1% (per mL): $110.00

Disclaimer: A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer. Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions. In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data. Pricing data is updated monthly.

Administration: Adult

Topical: For external use only; avoid contact with eyes. Wash and dry affected area before drug application. Ensure coverage of nail edges, cuticles, and skin around the nails. For tinea pedis, also apply to spaces between the toes.

Aerosol, aerosol powder: Shake well prior to use.

Administration: Pediatric

Topical: For external use only; avoid contact with eyes. Wash and dry affected area before drug application. For tinea pedis, also apply to spaces between the toes.

Aerosol, aerosol powder, solution: Shake well prior to use.

Use: Labeled Indications

Tinea corporis: Treatment of ringworm (tinea corporis).

Tinea cruris: Treatment of jock itch (tinea cruris).

Tinea pedis: Prevention and treatment of athlete's foot (tinea pedis).

Use: Off-Label: Adult

Tinea manuum

Medication Safety Issues
Sound-alike/look-alike issues:

Tinactin may be confused with Talacen

Metabolism/Transport Effects

None known.

Drug Interactions

There are no known significant interactions.

Mechanism of Action

Distorts the hyphae and stunts mycelial growth in susceptible fungi

Pharmacokinetics (Adult Data Unless Noted)

Onset of action: 24 to 72 hours

Brand Names: International
International Brand Names by Country
For country code abbreviations (show table)

  • (AE) United Arab Emirates: Tinea Cure;
  • (AR) Argentina: Tinaderm;
  • (AU) Australia: Scholls tinea | Tinaderm | Tineafax;
  • (CL) Chile: Tinactin | Tinaderm;
  • (DE) Germany: Sorgoa | Tinatox | Tolnaftat | Tonoftal;
  • (DO) Dominican Republic: Hongo killer | Secalia | Tinaderm | Ting | Tolnaftin;
  • (EC) Ecuador: Tinaderm | Zinoderm;
  • (EG) Egypt: Tineacure;
  • (ES) Spain: Micoisdin | Tinaderm;
  • (FR) France: Sporiline;
  • (GB) United Kingdom: Mycil | Mycil athlete's foot | Scholl Advance Athlete's Foot | Scholl athlet foot | Tinaderm | Tinaderm plus;
  • (HK) Hong Kong: Aftate;
  • (HU) Hungary: Athlete'S Foot | Chinofungin | Disifungin;
  • (IE) Ireland: Mycil | Tinaderm | Tinaderm plus;
  • (IL) Israel: Athlete'S Foot | Pitrex;
  • (IN) India: Tinaderm | Tolnaderm sterkem;
  • (IT) Italy: Tinaderm;
  • (LT) Lithuania: Fungal Nail;
  • (LU) Luxembourg: Sorgoa;
  • (LV) Latvia: Antifungal | Scholl athlete's foot;
  • (MX) Mexico: Excelsior mic | Tinaderm | Tinoxal;
  • (MY) Malaysia: Creobic | Myco-Aid | Scholl athlete's foot | Tinaderm | Tinalite | Tolnaderm;
  • (NZ) New Zealand: Savlon footcare | Tinaderm;
  • (PE) Peru: Tinaderm;
  • (PH) Philippines: Tinactin | Tolnaderm;
  • (PR) Puerto Rico: Breezee | Lamisil AF Defense | Q-Naftate | Tinactin | Tinactin Chill | Tinactin Foot & Sneaker Deodorant | Tineacide | Ting;
  • (PT) Portugal: Tinaderme;
  • (SA) Saudi Arabia: Tinea Cure;
  • (SG) Singapore: Hi vetic | Scholl athlete's foot | Tinaderm | Tolnaderm;
  • (TH) Thailand: Fugicid | Misone | Tolnaderm | Tonaf;
  • (TR) Turkey: Tinactin;
  • (TW) Taiwan: Naff | Tollfe | Tolnaf;
  • (VE) Venezuela, Bolivarian Republic of: Tinaderm | Tolnaftan;
  • (ZA) South Africa: Tinaderm
  1. American Academy of Pediatrics Committee on Drugs. "Inactive" ingredients in pharmaceutical products: update (subject review). Pediatrics. 1997;99(2):268-278. [PubMed 9024461]
  2. Goldstein AO, Goldstein BG. Dermatophyte (tinea) infections. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. http://www.uptodate.com. Accessed August 24, 2021.
  3. Micotrin AL (tolnaftate spray) [prescribing information]. Panorama City, CA: Pure Tek Corporation LLC; October 2021.
  4. Proclearz Max Strength Fungal Shield Brush-On Antifungal (tolnaftate solution liquid) [prescribing information]. Brooklyn, NY: PROFOOT, Inc.; March 2017.
  5. Refer to manufacturer's labeling.
  6. Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. Pediatr Crit Care Med. 2009;10(2):256-259. [PubMed 19188870]
  7. Tinactin Jock Itch (tolnaftate powder spray) [prescribing information]. Whippany, NJ: Bayer HealthCare LLC.
  8. Tinactin (tolnaftate deodorant powder spray) [prescribing information]. Whippany, NJ: Bayer HealthCare LLC.
  9. Tinactin (tolnaftate powder spray) [prescribing information]. Whippany, NJ: Bayer HealthCare LLC; received October 2019.
  10. Tinactin (tolnaftate spray) [prescribing information]. Whippany, NJ: Bayer HealthCare LLC.
  11. Tolnaftate 1% topical solution [prescribing information]. Allegan, MI: Perrigo Pharmaceuticals.
  12. Tolnaftate cream USP 1% [prescribing information]. Allegan, MI: Perrigo Pharmaceuticals.
  13. Weinstein A, Berman B. Topical treatment of common superficial tinea infections. Am Fam Physician. 2002;65(10):2095-2102. [PubMed 12046779]
Topic 10005 Version 288.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟